Showing results (11-20 of 360) with videos related to
Sort By:
Pageof 36
Journal of Virology|January 4, 2013
Neuroattenuation of vesicular stomatitis virus through picornaviral internal ribosome entry sitesArun Ammayappan, Rebecca Nace, Kah-Whye Peng, et al.Cancer Research|July 17, 2004
High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virusBambi D Anderson, Takafumi Nakamura, Stephen J Russell, et al.Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 20, 2019
Oncolytic Viruses: Priming Time for Cancer ImmunotherapyLuke Russell, Kah Whye Peng, Stephen J Russell, et al.Virology|November 3, 2004
Reengineering paramyxovirus tropismElizabeth M Hadac, Kah-Whye Peng, Takafumi Nakamura, et al.The Prostate|April 16, 2009
Prostate-specific membrane antigen retargeted measles virotherapy for the treatment of prostate cancerChunsheng Liu, Kosei Hasegawa, Stephen J Russell, et al.Human Gene Therapy|December 17, 2011
Retargeting vesicular stomatitis virus using measles virus envelope glycoproteinsCamilo Ayala-Breton, Glen N Barber, Stephen J Russell, et al.Nature Medicine|May 2, 2002
Non-invasive in vivo monitoring of trackable viruses expressing soluble marker peptidesKah-Whye Peng, Suzanne Facteau, Troy Wegman, et al.Blood|December 30, 2015
Immunovirotherapy with vesicular stomatitis virus and PD-L1 blockade enhances therapeutic outcome in murine acute myeloid leukemiaWeiwei Shen, Mrinal M Patnaik, Autumn Ruiz, et al.Experimental Hematology|February 14, 2013
Enhancing cytokine-induced killer cell therapy of multiple myelomaChunsheng Liu, Lukkana Suksanpaisan, Yun-Wen Chen, et al.Journal of Virology|May 16, 2014
Faster replication and higher expression levels of viral glycoproteins give the vesicular stomatitis virus/measles virus hybrid VSV-FH a growth advantage over measles virusCamilo Ayala-Breton, Luke O J Russell, Stephen J Russell, et al.Pageof 36